Sensus Healthcare to Showcase Superficial Radiotherapy for Non-Invasive Skin Cancer Treatment at JPM Week 2026 in San Francisco

miércoles, 7 de enero de 2026, 4:32 pm ET1 min de lectura
SRTS--

Sensus Healthcare, a medical device company specializing in non-invasive treatments for skin conditions, will hold investor meetings during the JPM Week 2026 conference in San Francisco. The company's management will discuss recent developments, including a new coding system for superficial radiotherapy and a growing international presence. The conference is expected to be exciting and productive for Sensus in 2026.

Sensus Healthcare to Showcase Superficial Radiotherapy for Non-Invasive Skin Cancer Treatment at JPM Week 2026 in San Francisco

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios